Ola Vedin works in Heart Failure & Transplant affiliated with AstraZeneca (Sweden).
Ola Vedin serves as the Global Clinical Head for Late Clinical CVRM at AstraZeneca in Sweden. He previously held positions at Boehringer Ingelheim and worked as a specialist in cardiology at Uppsala University Hospital. His research includes studies on heart failure treatments, cardiovascular risk factors, and related metabolic conditions.
65 pubs · 3,199 cites · h-index 27
Postgraduate Course in Heart Failure
University of Zurich
2017
PhD
Uppsala University
2015
MD
Uppsala University
2005
Global Clinical Head, Late Clinical CVRM
AstraZeneca · 2024 - Present
Executive Director, Late Clinical Development CVRM
AstraZeneca · 2023 - 2024
Scouting and Innovation Lead, Clinical Development Center of Excellence
Boehringer Ingelheim · 2021 - 2023
Global Medical Director Heart Failure
Boehringer Ingelheim · 2021 - 2021
Specialist in Cardiology and Internal Medicine
Uppsala University Hospital · 2015 - 2018